Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2004.

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission File Number: 000-30615

 


 

SIRENZA MICRODEVICES, INC.

(Exact name of registrant as specified in its charter)

 


 

Delaware   77-0073042

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

303 S. Technology Court, Broomfield, CO   80021
(Address of principal executive offices)   (Zip Code)

 

(303) 327-3030

(Registrant’s telephone number, including area code)

 

N/A

(Former name, former address and former fiscal year, if changed since last report)

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) had been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).    Yes  ¨    No  x

 

As of October 31, 2004 there were 34,920,936 shares of registrant’s Common Stock outstanding.

 



Table of Contents

SIRENZA MICRODEVICES, INC.

 

INDEX

 

          Page

Part I. Financial Information

   3

    Item 1.

   Financial Statements    3

    Item 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    12

    Item 3.

   Quantitative and Qualitative Disclosures About Market Risk    29

    Item 4.

   Controls and Procedures    30

Part II. Other Information

   30

    Item 1.

   Legal Proceedings    30

    Item 2.

   Unregistered Sales of Equity Securities and Use of Proceeds    30

    Item 3.

   Defaults Upon Senior Securities    31

    Item 4.

   Submission of Matters to a Vote of Security Holders    31

    Item 5.

   Other Information    31

    Item 6.

   Exhibits    31

     Signatures

   32


Table of Contents

Part I. Financial Information

 

Item 1. Financial Statements

 

SIRENZA MICRODEVICES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

ASSETS

 

    

September 30,

2004


   December 31,
2003


     (unaudited)     

Current assets:

             

Cash and cash equivalents

   $ 10,522    $ 7,468

Short-term investments

     —        1,999

Accounts receivable, net

     8,428      7,838

Inventories

     9,831      6,497

Other current assets

     707      1,093
    

  

Total current assets

     29,488      24,895

Property and equipment, net

     8,475      9,685

Long-term investments

     6,022      4,015

Investment in GCS

     4,600      4,600

Other assets

     1,408      1,189

Acquisition related intangibles, net

     4,364      5,529

Goodwill

     4,219      4,219
    

  

Total assets

   $ 58,576    $ 54,132
    

  

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

Current liabilities:

                

Accounts payable

   $ 4,519     $ 4,379  

Accrued expenses

     3,328       2,530  

Deferred margin on distributor inventory

     1,301       1,042  

Accrued restructuring

     366       887  

Capital lease obligations, current portion

     73       65  
    


 


Total current liabilities

     9,587       8,903  

Capital lease obligations and other long-term liabilities

     18       56  

Commitments and contigencies

                

Stockholders’ equity:

                

Common stock

     35       34  

Additional paid-in capital

     135,578       134,705  

Deferred stock compensation

     —         (3 )

Treasury stock, at cost

     (165 )     (165 )

Accumulated deficit

     (86,477 )     (89,398 )
    


 


Total stockholders’ equity

     48,971       45,173  
    


 


Total liabilities and stockholders’ equity

   $ 58,576     $ 54,132  
    


 


 

See accompanying notes.

 

3


Table of Contents

SIRENZA MICRODEVICES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

(Unaudited)

 

     Three Months Ended

    Nine Months Ended

 
     September 30,
2004


    September 30,
2003


    September 30,
2004


    September 30,
2003


 

Net revenues

   $ 16,737     $ 10,358     $ 46,191     $ 25,215  

Cost of revenues:

                                

Cost of product revenues

     8,219       5,728       23,607       13,319  

Amortization of deferred stock compensation

     —         22       —         68  
    


 


 


 


Total cost of revenues

     8,219       5,750       23,607       13,387  
    


 


 


 


Gross profit

     8,518       4,608       22,584       11,828  

Operating expenses:

                                

Research and development (exclusive of amortization of deferred stock compensation of $0, $2, $10 and $54 for the three and nine months ended September 30, 2004 and three and nine months ended September 30, 2003, respectively)

     2,337       2,348       6,777       6,220  

Sales and marketing (exclusive of amortization of deferred stock compensation of $0, $1, $43 and $130 for the three and nine months ended September 30, 2004 and three and nine months ended September 30, 2003, respectively)

     1,913       1,590       5,883       4,572  

General and administrative (exclusive of amortization of deferred stock compensation of $0, $0, $74 and $230 for the three and nine months ended September 30, 2004 and three and nine months ended September 30, 2003, respectively)

     2,174       1,669       5,938       4,694  

Amortization of deferred stock compensation

     —         127       3       414  

Amortization of acquisition related intangible assets

     354       431       1,165       782  

Restructuring

     (98 )     —         (98 )     434  
    


 


 


 


Total operating expenses

     6,680       6,165       19,668       17,116  
    


 


 


 


Income (loss) from operations

     1,838       (1,557 )     2,916       (5,288 )

Interest expense

     4       8       12       31  

Interest and other income, net

     75       89       152       378  
    


 


 


 


Income (loss) before income taxes

     1,909       (1,476 )     3,056       (4,941 )

Provision for income taxes

     86       —         135       —    
    


 


 


 


Net income (loss)

   $ 1,823     $ (1,476 )   $ 2,921     $ (4,941 )
    


 


 


 


Basic net income (loss) per share

   $ 0.05     $ (0.04 )   $ 0.08     $ (0.15 )
    


 


 


 


Diluted net income (loss) per share

   $ 0.05     $ (0.04 )   $ 0.08     $ (0.15 )
    


 


 


 


Shares used to compute basic net income (loss) per share

     34,696       33,541       34,446       31,889  
    


 


 


 


Shares used to compute diluted net income (loss) per share

     37,384       33,541       37,270       31,889  
    


 


 


 


 

See accompanying notes.

 

4


Table of Contents

SIRENZA MICRODEVICES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

     Nine Months Ended

 
    

September 30,

2004


   

September 30,

2003


 

Operating Activities

                

Net income (loss)

   $ 2,921     $ (4,941 )

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

                

Depreciation and amortization

     4,394       3,459  

Amortization of deferred stock compensation

     3       482  

Compensation expense related to employee equity awards

     37       —    

Gain on the sale of property and equipment

     —         (112 )

Changes in operating assets and liabilities:

                

Accounts receivable

     (590 )     (3,140 )

Inventories

     (3,334 )     (2,132 )

Other assets

     167       55  

Accounts payable

     140       1,713  

Accrued expenses

     816       (327 )

Accrued restructuring

     (521 )     (844 )

Deferred margin on distributor inventory

     259       (1,032 )
    


 


Net cash provided by (used in) operating activities

     4,292       (6,819 )

Investing Activities

                

Sales/maturities (purchases) of available-for-sale securities, net

     (8 )     12,013  

Purchases of property and equipment

     (2,019 )     (2,225 )

Proceeds from the sale of property and equipment

     —         112  

Purchase of Xemod, net of cash received

     —         28  

Purchase of Vari-L, net of amounts accrued

     —         (7,556 )

Increase in restricted cash

     —         (1,100 )
    


 


Net cash provided by (used in) investing activities

     (2,027 )     1,272  

Financing Activities

                

Principal payments on capital lease obligations

     (48 )     (414 )

Proceeds from employee stock plans

     837       472  
    


 


Net cash provided by financing activities

     789       58  

Increase (decrease) in cash and cash equivalents

     3,054       (5,489 )

Cash and cash equivalents at beginning of period

     7,468       12,874  
    


 


Cash and cash equivalents at end of period

   $ 10,522     $ 7,385  
    


 


Supplemental disclosures of noncash investing and financing activities

                

Cost and accumulated depreciation of equipment retired

   $ 83     $ —    

Forfeiture of deferred stock compensation

   $ —       $ 138  

Common stock issued in connection with Vari-L acquisition

   $ —       $ 4,654  

Assumption of Vari-L loans receivable

  <